DOR/ISL Phase III data underlines trend for shift towards two-drug STRs in HIV
A 96-week Phase III study in adults with HIV who were previously virologically suppressed on oral antiretroviral therapy (ART) has…
A 96-week Phase III study in adults with HIV who were previously virologically suppressed on oral antiretroviral therapy (ART) has…
Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010. This announcement comes…
Alzheimer’s disease is the most common type of dementia globally. It is characterised by memory loss, cognitive impairment, and a…
The World Health Organization (WHO) announced this month that a novel oral polio vaccine type 2 (nOPV2) has been prequalified.…
According to the World Health Organization, approximately one in eight people worldwide was living with obesity in 2022. Obesity is…
The societal and economic impacts of the Covid-19 pandemic included a variety of downstream effects on health endpoints worldwide. Among…
Globally, cancer is a leading cause of death and presents a significant challenge to public health. Despite major therapeutic advances…
World Neglected Tropical Disease (NTD) Day is an opportunity to highlight leishmaniasis not only as an ongoing health challenge, but…
Respiratory tract infections (RTIs) are widely prevalent and cause significant morbidity and mortality globally. RTIs are broadly divided into upper…
Breast cancer is the second most common type of cancer in women, according to the Mayo Clinic, and while survival…